Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

SYRE Spyre Therapeutics Inc

24.35

0.50 (2.10%)

Jan 03 2025 - Closed

Delayed by 15 minutes

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

null

Spyre Therapeutics (NASDAQ:SYRE)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Spyre Therapeutics Charts.

Spyre Therapeutics (NASDAQ:SYRE)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Spyre Therapeutics Charts.

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Share on Facebook Share on Twitter Share on Email

Loading Messages....

See More Message Board Posts

Spyre Therapeutics Inc News

More Spyre Therapeutics Inc News Articles

Global Developments (PK)

Anavex Life Sciences

Northwest Biotherapeutics (QB)

Fannie Mae (QB)

Kraig Biocraft Laborator... (QB)

Lightwave Logic

Elite Pharmaceuticals (QB)

Decentral Life (PK)

Digital Brand Media and ... (PK)

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions